tiprankstipranks
Trending News
More News >
Novartis AG (DE:NOT)
XETRA:NOT

Compare Novartis AG (NOT) vs. Competitors

Compare
23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Novartis AG
€126.62
€240.73B
18.30
57.61%
7 Buy
5 Hold
2 Sell
Moderate Buy
Roche Holding AG
CHF300.90
CHF240.33B
11.94
-1.70%
7 Buy
4 Hold
2 Sell
Moderate Buy
Lonza Group Ltd
CHF473.30
CHF31.80B
19.54
-16.47%
8 Buy
0 Hold
0 Sell
Strong Buy
Alcon
CHF58.22
CHF29.09B
38.35
-27.93%
9 Buy
4 Hold
1 Sell
Moderate Buy
Galderma Group AG
CHF142.10
CHF33.37B
75.41
45.48%
7 Buy
1 Hold
0 Sell
Strong Buy
Roche Holding Ltd
CHF335.20
CHF240.33B
20.28
-3.79%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:NOT
Novartis AG
126.62
48.68
62.46%
CH:ROG
Roche Holding AG
300.90
15.18
5.31%
CH:LONN
Lonza Group Ltd
473.30
-90.95
-16.12%
CH:ALC
Alcon
58.22
-23.25
-28.54%
CH:GALD
Galderma Group AG
142.10
47.12
49.61%
CH:RO
Roche Holding Ltd
309.60
6.85
2.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts